DrReposER ID |
PDB |
Ligand |
Organism |
Macromolecule |
Pfam |
Res. |
Interface |
HETATM |
3SOA_A_DB8A445 |
3soa |
DB8 DB06616(Bosutinib) |
Homo sapiens |
CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE TYPE IISUBUNIT ALPHA WITH ABETA 7 LINKER |
PF00069(Pkinase)PF08332(CaMKII_AD) |
6 |
LEU A 19VAL A 27MET A 42PHE A 89VAL A 92PHE A 157 |
DB8 A 445
|
5B8I_C_FK5C201 |
5b8i |
FK5 DB00864(Tacrolimus) |
Coccidioidesimmitis |
CALCINEURIN SUBUNITB, VARIANT;PEPTIDYL-PROLYLCIS-TRANS ISOMERASE;SERINE/THREONINE-PROTEIN PHOSPHATASE |
PF00149(Metallophos)PF00254(FKBP_C)PF13202(EF-hand_5)PF13499(EF-hand_7) |
22 |
TYR C 36ASP C 56ARG C 61PHE C 64VAL C 73ILE C 74TRP C 77TYR C 100PHE C 105LEU C 108ILE C 109LEU B 116PHE C 117MET B 119VAL B 120ASN B 123LEU A 361TRP A 370SER A 371PRO A 373PHE A 374GLU A 377 |
FK5 C 201
|
5V02_R_657R201 |
5v02 |
657 DB00740(Riluzole) |
Homo sapiens |
CALMODULIN-1;SMALL CONDUCTANCECALCIUM-ACTIVATEDPOTASSIUM CHANNELPROTEIN 2 |
PF02888(CaMBD)PF13499(EF-hand_7) |
10 |
LEU R 32MET R 51GLU R 54VAL R 55ILE R 63MET R 71MET R 72ALA B 477LEU B 480VAL B 481 |
657 R 201
|
5WEO_A_CYZA1302 |
5weo |
CYZ DB00606(Cyclothiazide) |
Mus musculus;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNITCHIMERA |
PF00060(Lig_chan)PF00822(PMP22_Claudin)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd)no annotation |
10 |
ILE D 481PRO A 494PRO D 494MET A 496SER A 497SER D 497SER D 729GLY D 731ASP A 760LYS A 763 |
CYZ A1302
|
5WEO_B_CYZB1302 |
5weo |
CYZ DB00606(Cyclothiazide) |
Mus musculus;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNITCHIMERA |
no annotation |
9 |
ILE C 481PRO C 494PRO B 494MET B 496SER B 497SER C 729GLY C 731ASP B 760LYS B 763 |
CYZ B1302
|
5WEO_C_CYZC1302 |
5weo |
CYZ DB00606(Cyclothiazide) |
Mus musculus;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNITCHIMERA |
no annotation |
9 |
PRO C 494PRO B 494MET C 496SER B 497SER C 497SER B 729GLY B 731ASP C 760LYS C 763 |
CYZ C1302
|
5WEO_D_CYZD1302 |
5weo |
CYZ DB00606(Cyclothiazide) |
Mus musculus;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNITCHIMERA |
PF00060(Lig_chan)PF00822(PMP22_Claudin)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd)no annotation |
9 |
ILE A 481PRO A 494PRO D 494MET D 496SER D 497SER A 729GLY A 731ASP D 760LYS D 763 |
CYZ D1302
|
6DLZ_A_CYZA1302 |
6dlz |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) |
10 |
ILE D 481PRO A 494MET A 496SER A 497SER D 729GLY D 731LEU A 751SER A 754ASP A 760LYS A 763 |
CYZ A1302
|
6DLZ_B_CYZB1302 |
6dlz |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE C 481PRO C 494MET B 496SER B 497SER C 729LEU B 751SER B 754LEU B 759ASP B 760LYS B 763 |
CYZ B1302
|
6DLZ_C_CYZC1302 |
6dlz |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE B 481PRO C 494MET C 496SER C 497SER B 729GLY B 731LEU C 751SER C 754ASP C 760LYS C 763 |
CYZ C1302
|
6DLZ_D_CYZD1302 |
6dlz |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) |
11 |
ILE A 481PRO A 494PRO D 494MET D 496SER D 497SER A 729LEU D 751SER D 754LEU D 759ASP D 760LYS D 763 |
CYZ D1302
|
6DM0_A_CYZA1302 |
6dm0 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan-Glu_bd)PF01094(Lig_chan)PF10613(ANF_receptor) |
9 |
ILE D 481PRO A 494MET A 496SER A 497SER D 729LEU A 751SER A 754ASP A 760LYS A 763 |
CYZ A1302
|
6DM0_B_CYZB1302 |
6dm0 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE C 481PRO C 494MET B 496SER B 497SER C 729GLY C 731LEU B 751LEU B 759ASP B 760LYS B 763 |
CYZ B1302
|
6DM0_C_CYZC1302 |
6dm0 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
9 |
ILE B 481PRO C 494MET C 496SER C 497SER B 729LEU C 751SER C 754ASP C 760LYS C 763 |
CYZ C1302
|
6DM0_D_CYZD1302 |
6dm0 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan-Glu_bd)PF01094(Lig_chan)PF10613(ANF_receptor) |
9 |
PRO A 494MET D 496SER D 497SER A 729GLY A 731LEU D 751LEU D 759ASP D 760LYS D 763 |
CYZ D1302
|
6DM1_A_CYZA1302 |
6dm1 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(ANF_receptor)PF00822(Lig_chan)PF01094(Lig_chan-Glu_bd)PF10613(PMP22_Claudin) |
10 |
ILE D 481PRO A 494MET A 496SER A 497SER D 729GLY D 731LEU A 751SER A 754ASP A 760LYS A 763 |
CYZ A1302
|
6DM1_B_CYZB1302 |
6dm1 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE C 481PRO C 494MET B 496SER B 497SER C 729LEU B 751SER B 754LEU B 759ASP B 760LYS B 763 |
CYZ B1302
|
6DM1_C_CYZC1302 |
6dm1 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE B 481PRO C 494MET C 496SER C 497SER B 729GLY B 731LEU C 751SER C 754ASP C 760LYS C 763 |
CYZ C1302
|
6DM1_D_CYZD1302 |
6dm1 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(ANF_receptor)PF00822(Lig_chan)PF01094(Lig_chan-Glu_bd)PF10613(PMP22_Claudin) |
11 |
ILE A 481PRO A 494PRO D 494MET D 496SER D 497SER A 729LEU D 751SER D 754LEU D 759ASP D 760LYS D 763 |
CYZ D1302
|
6DM2_A_CYZA1302 |
6dm2 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) |
9 |
ILE D 481PRO A 494MET A 496SER A 497SER D 729LEU A 751SER A 754ASP A 760LYS A 763 |
CYZ A1302
|
6DM2_B_CYZB1302 |
6dm2 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE C 481PRO C 494MET B 496SER B 497SER C 729LEU B 751SER B 754LEU B 759ASP B 760LYS B 763 |
CYZ B1302
|
6DM2_C_CYZC1302 |
6dm2 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
9 |
ILE B 481PRO C 494MET C 496SER C 497SER B 729LEU C 751SER C 754ASP C 760LYS C 763 |
CYZ C1302
|
6DM2_D_CYZD1302 |
6dm2 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) |
10 |
ILE A 481PRO A 494MET D 496SER D 497SER A 729LEU D 751SER D 754LEU D 759ASP D 760LYS D 763 |
CYZ D1302
|